336 related articles for article (PubMed ID: 16231052)
1. Gutless adenovirus: last-generation adenovirus for gene therapy.
Alba R; Bosch A; Chillon M
Gene Ther; 2005 Oct; 12 Suppl 1():S18-27. PubMed ID: 16231052
[TBL] [Abstract][Full Text] [Related]
2. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
Sargent KL; Ng P; Evelegh C; Graham FL; Parks RJ
Gene Ther; 2004 Mar; 11(6):504-11. PubMed ID: 14999222
[TBL] [Abstract][Full Text] [Related]
3. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
Ng P; Beauchamp C; Evelegh C; Parks R; Graham FL
Mol Ther; 2001 May; 3(5 Pt 1):809-15. PubMed ID: 11356086
[TBL] [Abstract][Full Text] [Related]
4. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
[TBL] [Abstract][Full Text] [Related]
5. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.
Parks R; Evelegh C; Graham F
Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766
[TBL] [Abstract][Full Text] [Related]
6. Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses.
Barjot C; Hartigan-O'Connor D; Salvatori G; Scott JM; Chamberlain JS
J Gene Med; 2002; 4(5):480-9. PubMed ID: 12221641
[TBL] [Abstract][Full Text] [Related]
7. Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination.
Umaña P; Gerdes CA; Stone D; Davis JR; Ward D; Castro MG; Lowenstein PR
Nat Biotechnol; 2001 Jun; 19(6):582-5. PubMed ID: 11385466
[TBL] [Abstract][Full Text] [Related]
8. Helper-dependent adenovirus vectors devoid of all viral genes cause less myocardial inflammation compared with first-generation adenovirus vectors.
Fleury S; Driscoll R; Simeoni E; Dudler J; von Segesser LK; Kappenberger L; Vassalli G
Basic Res Cardiol; 2004 Jul; 99(4):247-56. PubMed ID: 15221342
[TBL] [Abstract][Full Text] [Related]
9. Production of helper-dependent adenovirus vector relies on helper virus structure and complementing.
Zhou HS; Zhao T; Rao XM; Beaudet AL
J Gene Med; 2002; 4(5):498-509. PubMed ID: 12221643
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK
Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
[TBL] [Abstract][Full Text] [Related]
11. Long-term in vivo transduction of neurons throughout the rat CNS using novel helper-dependent CAV-2 vectors.
Soudais C; Skander N; Kremer EJ
FASEB J; 2004 Feb; 18(2):391-3. PubMed ID: 14688208
[TBL] [Abstract][Full Text] [Related]
12. The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cells.
Shi CX; Long MA; Liu L; Graham FL; Gauldie J; Hitt MM
Mol Ther; 2004 Oct; 10(4):758-67. PubMed ID: 15451460
[TBL] [Abstract][Full Text] [Related]
13. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.
Cheshenko N; Krougliak N; Eisensmith RC; Krougliak VA
Gene Ther; 2001 Jun; 8(11):846-54. PubMed ID: 11423932
[TBL] [Abstract][Full Text] [Related]
14. Replication and packaging of helper-dependent adenoviral vectors.
Sato M; Suzuki S; Kubo S; Mitani K
Gene Ther; 2002 Apr; 9(7):472-6. PubMed ID: 11938462
[TBL] [Abstract][Full Text] [Related]
15. Differential amplification of adenovirus vectors by flanking the packaging signal with attB/attP-PhiC31 sequences: implications for helper-dependent adenovirus production.
Alba R; Hearing P; Bosch A; Chillon M
Virology; 2007 Oct; 367(1):51-8. PubMed ID: 17560622
[TBL] [Abstract][Full Text] [Related]
16. Production of first generation adenovirus vectors: a review.
Danthinne X; Imperiale MJ
Gene Ther; 2000 Oct; 7(20):1707-14. PubMed ID: 11083491
[TBL] [Abstract][Full Text] [Related]
17. Genetic targeting strategies for adenovirus.
Noureddini SC; Curiel DT
Mol Pharm; 2005; 2(5):341-7. PubMed ID: 16196486
[TBL] [Abstract][Full Text] [Related]
18. Optimization of the generation and propagation of gutless adenoviral vectors.
Sakhuja K; Reddy PS; Ganesh S; Cantaniag F; Pattison S; Limbach P; Kayda DB; Kadan MJ; Kaleko M; Connelly S
Hum Gene Ther; 2003 Feb; 14(3):243-54. PubMed ID: 12639304
[TBL] [Abstract][Full Text] [Related]
19. A convenient plasmid system for construction of helper-dependent adenoviral vectors and its application for analysis of the breast-cancer-specific mammaglobin promoter.
Shi CX; Graham FL; Hitt MM
J Gene Med; 2006 Apr; 8(4):442-51. PubMed ID: 16389604
[TBL] [Abstract][Full Text] [Related]
20. High-capacity 'gutless' adenoviral vectors.
Kochanek S; Schiedner G; Volpers C
Curr Opin Mol Ther; 2001 Oct; 3(5):454-63. PubMed ID: 11699889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
